stella
beta
Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis — Stella
Recruiting
Back to NSCLC (Advanced Non-small Cell Lung Cancer) trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong
View full record on ClinicalTrials.gov